Ketone drink for confusion in intensive care patients
Part of Hormones & metabolism clinical trials.
This trial tests whether giving a special ketone drink to patients in the ICU can reduce or treat delirium (confusion). If you or a loved one is in the ICU, this treatment might help clear up confusion faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be in the intensive care unit (ICU) and expected to stay at least 24 hours
- You must be able to take the study drink by mouth or through a feeding tube
- You must be able to answer questions to check for confusion
- You cannot have severe metabolic problems or certain conditions like uncontrolled diabetes
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special diet drink (ketone body supplement) for ICU patients who are starting tube feeding. It looks at whether the drink can help the body use energy in a different way, possibly improving recovery.
This trial tests a special ketone drink to see if it can help people recently hospitalized with acute heart failure feel better and recover faster. It measures how the drink affects the heart and body during the early days in the hospital.
This study tests whether a ketone drink can change how the body uses energy in people with bipolar disorder. It may help understand new ways to manage the condition.
This study tests if a ketone supplement can reduce protein in urine and protect kidney function in people with chronic kidney disease or polycystic kidney disease. You drink a special supplement and researchers measure how it affects your kidneys.
This study tests whether a drink containing ketones (a natural energy source for the brain) can improve thinking and memory. It involves three groups: people with obesity, lean people, and athletes.
This Phase 2 trial tests whether melatonin can reduce delirium, a sudden confusion that can happen in the ICU. If you qualify, you may be given melatonin to see if it improves alertness and comfort during an expected longer ICU stay.
Hear when a new ICU Delirium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.